Hyperemesis Gravidarum Clinical Trial
— PUQE-NOfficial title:
Case-cohort Validation Study of Pregnancy Unique Questionnaire of Emesis (PUQE) in Norwegian
Nausea in early pregnancy (emesis gravidarum) is very common but most often self-limiting. Hyperemesis gravidarum; where nausea and vomiting is severe and protracted is potentially dangerous for the woman and her foetus and necessitates hospital treatment. An English questionnaire (PUQE; Pregnancy Unique Questionnaire of Emesis) exists that can differentiate between uncomplicated emesis and the severe hyperemesis condition. This questionnaire has been translated to Norwegian. The investigators want to test the ability of this questionnaire to differentiate the grade of nausea/vomiting between a group of presumed normal pregnant woman and patients treated for hyperemesis gravidarum in a Norwegian population. The investigators also want to relate the PUQE questionnaire scoring to the women/patients' self-reported nutritional intake during 24 hours.
Status | Completed |
Enrollment | 69 |
Est. completion date | January 2015 |
Est. primary completion date | April 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 16 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Pregnant healthy women (controls) - Patients admitted to hospital for hyperemesis gravidarum Exclusion Criteria: - Pregnancy duration at inclusion more than 16 weeks - Unable to understand and read/write Norwegian - Conditions other than hyperemesis leading to nausea/vomiting |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Norway | Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital | Bergen | Hordaland |
Norway | Dpt Obstetrics Gynaecology, Stavanger University Hospital | Stavanger | Rogaland |
Lead Sponsor | Collaborator |
---|---|
Haukeland University Hospital |
Norway,
Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, Navioz Y, Ungar WJ. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol. 2005 Apr;25(3):241-4. — View Citation
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008 Jan;198(1):71.e1-7. doi: 10.1016/j.ajog.2007.05.051. — View Citation
van Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol. 1995 May;172(5):1585-91. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score from hospital admittance to discharge | Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score for hyperemesis gravidarum patients from first assessment at hospital admission and again at hospital discharge | From hospital admission to discharge, mean 7 days | No |
Other | Pregnancy Unique Questionnaire of Emesis (PUQE) score at inclusion related to change in patient weight (kg)from start of pregnancy to inclusion for hyperemesis patients versus normal pregnant women | Change of weight (gain or loss) from pre-pregnant to time of inclusion related to Pregnancy Unique Questionnaire of Emesis (PUQE) scores for hyperemesis and control women | From pre-pregnancy to inclusion (mean 9 weeks pregnancy length) | No |
Other | Change of Pregnancy Unique Questionnaire of Emesis (PUQE) score and patient weight (kg) | Change of weight (gain or loss) from inclusion to time of delivery related to Pregnancy Unique Questionnaire of Emesis (PUQE) scores at inclusion for hyperemesis and control women | From inclusion to delivery (mean 7 months) | No |
Other | Pregnancy Unique Questionnaire of Emesis (PUQE) score related to the baby's weight (kg)in hyperemesis patients versus normal pregnant women | Pregnancy Unique Questionnaire of Emesis (PUQE) scores at inclusion for hyperemesis versus control women is related to the baby's weight at delivery | From inclusion to delivery (mean 7 months) | No |
Primary | Pregnancy Unique Questionnaire of Emesis (PUQE) score reported by hyperemesis patients versus normal pregnant women | Pregnancy Unique Questionnaire of Emesis (PUQE) score range from 3 to 15. Scores reported for the first 24 hours after inclusion will be compared between hyperemesis patients and healthy pregnant control women | 24 hours after inclusion | No |
Secondary | Pregnancy Unique Questionnaire of Emesis (PUQE) score in relation to self reported 24 hours nutritional intake registration (estimated caloric intake)in hyperemesis patients versus normal pregnant women | The Pregnancy Unique Questionnaire of Emesis (PUQE) scores from hyperemesis and control women will be compared to self-reported 24 hours nutritional intake | 24 hours after inclusion | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04785911 -
Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT04719286 -
MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy
|
N/A | |
Completed |
NCT02300155 -
Improving Multivitamin Supplementation to Pregnant Women
|
Phase 4 | |
Completed |
NCT05175079 -
Acupressure in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT05098067 -
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
|
Phase 2 | |
Completed |
NCT03950167 -
Gallbladder Functions & Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum
|
||
Completed |
NCT02830321 -
The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women
|
N/A | |
Completed |
NCT02541682 -
Assessment of the Relationship Between Affective Temperament and the Severity of Nausea and Vomiting in Early Pregnancy
|
N/A | |
Terminated |
NCT03785691 -
Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
|
Phase 2 | |
Completed |
NCT05446025 -
The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum
|
||
Recruiting |
NCT02862496 -
Bone Health in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT02163434 -
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
|
Phase 2 | |
Terminated |
NCT05452174 -
Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06442813 -
Effects Of Emotional Freedom Technique and Hypermesis Gravidarum
|
N/A | |
Completed |
NCT06245811 -
Inflammation Markers in Hyperemesis Gravidarum
|
||
Recruiting |
NCT06266819 -
The Effect of Mint Flavored Chewing Gum on Hyperemesis Gravidarum Nausea Vomiting Severity, Coping With Stress and Anxiety Level in Pregnants With Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT04828967 -
Use of Hypnosis in Hyperemesis Gravidarum
|
N/A | |
Completed |
NCT03127293 -
Hyperemesis Gravidarum and Osteoporosis
|
N/A | |
Completed |
NCT01559012 -
Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum
|
Phase 3 |